A Low Geriatric Nutritional Risk Index Is Associated with Low Muscle Volume and a Poor Prognosis among Cirrhotic Patients
Authors:
- Hirayuki EnomotoHEHirayuki Enomoto
- Yukihisa YuriYYYukihisa Yuri
- Takashi NishimuraTNTakashi Nishimura
- Naoto IkedaNINaoto Ikeda
- Tomoyuki TakashimaTTTomoyuki Takashima
- Nobuhiro AizawaNANobuhiro Aizawa
- Mamiko OkamotoMOMamiko Okamoto
- Kohei YoshiharaKYKohei Yoshihara
- Ryota YoshiokaRYRyota Yoshioka
- Shoki KawataSKShoki Kawata
- Yuta KawaseYKYuta Kawase
- Ryota NakanoRNRyota Nakano
Open Access
Abstract
Background and Objectives: The geriatric nutritional risk index (GNRI) is an easily calculable index that can be determined using three common clinical variables. The GNRI is suggested to be related to sarcopenia in cirrhotic patients. However, the relationship between the GNRI and the prognosis in patients with liver cirrhosis (LC) has not been reported. The aim of the present research is to study the association of the GNRI with the nutritional status, hepatic function reserve, and prognosis in patients with liver cirrhosis (LC). Materials and Methods: A total of 370 cirrhotic patients whose nutritional statuses were evaluated using anthropometric measurements and bioimpedance analysis were studied. The associations between the GNRI and nutritional status and the GNRI and hepatic function reserve were analyzed. We also investigated the GNRI and prognosis of patients with LC. Results: The median age of the enrolled patients was 66 years old, and 266 (71.9%) patients had viral hepatitis-related LC. The GNRI was shown to decrease with the progression of chronic liver disease, represented by an increased FIB-4 index and severe Child–Pugh and mALBI grades. In addition, a low GNRI (2 for men or 2 for women), as determined by using bioimpedance analysis. In addition, patients with a low GNRI (p = 0.0161, and generalized Wilcoxon test, p = 0.01261). Conclusions: Our results suggest that a low GNRI is related to severe chronic liver disease, low muscle volume, and a poor prognosis of patients with cirrhosis.Keywords
This publication has 33 references indexed in Scilit:
- Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and TreatmentJournal of the American Medical Directors Association, 2020
- The Anthropometric Assessment With the Bioimpedance Method Is Associated With the Prognosis of Cirrhotic PatientsIn Vivo, 2020
- EASL Clinical Practice Guidelines on nutrition in chronic liver diseaseJournal of Hepatology, 2019
- Sarcopenia: revised European consensus on definition and diagnosisAge and Ageing, 2018
- Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic FunctionLiver Cancer, 2017
- Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteriaHepatology Research, 2016
- Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI GradeJournal of Clinical Oncology, 2015
- Free fatty acid as a marker of energy malnutrition in liver cirrhosisHepatology Research, 2013
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006
- Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patientsThe American Journal of Clinical Nutrition, 2005